Peter P. Tóth

27.0k total citations · 8 hit papers
529 papers, 16.7k citations indexed

About

Peter P. Tóth is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter P. Tóth has authored 529 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 340 papers in Surgery, 237 papers in Endocrinology, Diabetes and Metabolism and 143 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter P. Tóth's work include Lipoproteins and Cardiovascular Health (307 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (194 papers) and Cancer, Lipids, and Metabolism (82 papers). Peter P. Tóth is often cited by papers focused on Lipoproteins and Cardiovascular Health (307 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (194 papers) and Cancer, Lipids, and Metabolism (82 papers). Peter P. Tóth collaborates with scholars based in United States, Poland and United Kingdom. Peter P. Tóth's co-authors include Maciej Banach, Steven R. Jones, Seth S. Martin, Michael J. Blaha, Manfredi Rizzo, Dimitri P. Mikhailidis, Roger S. Blumenthal, Michael H. Davidson, Daniel J. Rader and Jacek Rysz and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Circulation.

In The Last Decade

Peter P. Tóth

508 papers receiving 16.2k citations

Hit Papers

Comparison of a Novel Method vs the Friedewald Equation f... 2011 2026 2016 2021 2013 2011 2011 2020 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
    2013 551 citations Seth S. Martin, Michael J. Blaha et al. profile →
  2. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
    2011 465 citations Peter P. Tóth et al. Journal of clinical lipidology profile →
  3. Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
    2011 397 citations Peter P. Tóth et al. Journal of clinical lipidology profile →
  4. Inflammation and cardiovascular disease: From mechanisms to therapeutics
    2020 259 citations Seth S. Martin, Erin D. Michos et al. SHILAP Revista de lepidopterología profile →
  5. Prevalence of statin intolerance: a meta-analysis
    2022 255 citations Dimitri P. Mikhailidis, Mohsen Mazidi et al. European Heart Journal profile →
  6. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
    2022 151 citations Matthew J. Budoff, Erin D. Michos et al. SHILAP Revista de lepidopterología profile →
  7. Ten things to know about ten cardiovascular disease risk factors
    2021 150 citations Erin D. Michos, Michael D. Shapiro et al. SHILAP Revista de lepidopterología profile →
  8. Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024
    2024 42 citations Peter P. Tóth et al. Journal of clinical lipidology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter P. Tóth United States 68 8.4k 5.4k 3.9k 2.2k 2.2k 529 16.7k
Robert S. Rosenson United States 61 8.7k 1.0× 4.8k 0.9× 5.1k 1.3× 2.2k 1.0× 2.4k 1.1× 386 16.6k
Terry A. Jacobson United States 70 9.1k 1.1× 4.8k 0.9× 3.5k 0.9× 1.6k 0.7× 1.4k 0.7× 218 17.3k
Harold Bays United States 71 10.0k 1.2× 7.2k 1.3× 3.4k 0.9× 2.2k 1.0× 2.2k 1.0× 356 19.0k
Paul N. Durrington United Kingdom 68 7.6k 0.9× 6.6k 1.2× 3.3k 0.8× 1.8k 0.8× 2.6k 1.2× 287 19.9k
Željko Reiner Croatia 47 6.8k 0.8× 3.7k 0.7× 3.8k 1.0× 1.6k 0.7× 1.5k 0.7× 265 13.3k
Helen M. Colhoun United Kingdom 65 8.0k 1.0× 8.8k 1.6× 4.2k 1.1× 1.2k 0.5× 2.3k 1.1× 278 19.3k
Raúl D. Santos Brazil 48 5.9k 0.7× 3.6k 0.7× 3.5k 0.9× 1.6k 0.7× 1.4k 0.7× 375 12.8k
S. Matthijs Boekholdt Netherlands 62 6.7k 0.8× 5.4k 1.0× 5.3k 1.3× 1.8k 0.8× 1.5k 0.7× 293 14.5k
Michael H. Davidson United States 81 12.9k 1.5× 8.4k 1.5× 4.5k 1.1× 3.3k 1.5× 2.9k 1.3× 420 23.1k
Chris J. Packard United Kingdom 68 8.1k 1.0× 7.4k 1.4× 4.8k 1.2× 2.4k 1.1× 2.5k 1.2× 209 19.1k

Countries citing papers authored by Peter P. Tóth

Since Specialization
Citations

This map shows the geographic impact of Peter P. Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter P. Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter P. Tóth more than expected).

Fields of papers citing papers by Peter P. Tóth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter P. Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter P. Tóth. The network helps show where Peter P. Tóth may publish in the future.

Co-authorship network of co-authors of Peter P. Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Peter P. Tóth. A scholar is included among the top collaborators of Peter P. Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter P. Tóth. Peter P. Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zadeh, Seyed Saeed Tamehri, et al.. (2025). ANGPTL3 vital role in different kidney diseases. Current knowledge and future perspectives. Biomedicine & Pharmacotherapy. 188. 118189–118189.
2.
Janovsky, Carolina Castro Porto Silva, William R. Tebar, João Roberto Maciel Martins, et al.. (2025). The Metabolic Vulnerability Index (MVX) in Subclinical Thyroid Disorders and Euthyroidism: A Cross-Sectional Exploratory Analysis from the ELSA-Brasil Study. Metabolites. 15(9). 606–606.
3.
Ungvari, Anna, Rafał Gulej, Roland Patai, et al.. (2025). Age-Related Alterations of Cerebral Autoregulation. Life. 15(11). 1669–1669.
4.
Lewek, Joanna, Agata Bielecka‐Dąbrowa, Peter P. Tóth, & Maciej Banach. (2024). Dyslipidaemia management in pregnant patients: a 2024 update. European Heart Journal Open. 4(3). oeae032–oeae032. 20 indexed citations
5.
Filtz, Annalisa, Andrea Scotti, Juan J. Badimón, et al.. (2024). New approaches to triglyceride reduction: Is there any hope left?. SHILAP Revista de lepidopterología. 18. 100648–100648. 9 indexed citations
6.
Surma, Stanisław, et al.. (2023). Eliminating atherosclerotic cardiovascular disease residual risk. European Heart Journal. 44(45). 4731–4733. 18 indexed citations
7.
8.
9.
Budoff, Matthew J., Suvasini Lakshmanan, Peter P. Tóth, et al.. (2022). Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement✰. SHILAP Revista de lepidopterología. 9. 100318–100318. 27 indexed citations
10.
Jozwiak, Jacek Jerzy, Tomasz Tomasik, Adam Windak, et al.. (2020). The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. Atherosclerosis Supplements. 42. e15–e24. 18 indexed citations
11.
Fogacci, Federica, Nicola Ferri, Peter P. Tóth, et al.. (2019). Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Drugs. 79(7). 751–766. 98 indexed citations
12.
Ray, Kausik K., Stephen J. Nicholls, Jan O. Johansson, et al.. (2018). Abstract 13189: Cardiovascular Evaluation of the Selective BET Inhibitor, Apabetalone, in ACS Patients With Diabetes: Baseline Characteristics of the BETonMACE CV Outcomes Study. Circulation. 1 indexed citations
13.
Mazidi, Mohsen, Peter P. Tóth, & Maciej Banach. (2017). C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults. Angiology. 69(5). 438–442. 58 indexed citations
14.
Gluba-Brzózka, Anna, Marta Michalska, Beata Franczyk, et al.. (2016). Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. Lipids in Health and Disease. 15(1). 22–22. 26 indexed citations
15.
Quispe, Renato, Mohammed Al‐Hijji, Kristopher J. Swiger, et al.. (2015). Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9. Journal of clinical lipidology. 9(4). 511–518.e5. 5 indexed citations
16.
Brewer, H B, Peter P. Tóth, Daniel Rader, & Jean‐Claude Tardif. (2015). The Role of HDL-C in the Management of Atherosclerosis. 2 indexed citations
17.
Csiszár, Anna, Danuta Sosnowska, Zsuzsanna Tucsek, et al.. (2012). Circulating Factors Induced by Caloric Restriction in the Nonhuman Primate Macaca Mulatta Activate Angiogenic Processes in Endothelial Cells. The Journals of Gerontology Series A. 68(3). 235–249. 47 indexed citations
18.
Tóth, Peter P.. (2010). Pharmacomodulation of High-Density Lipoprotein Metabolism as a Therapeutic Intervention for Atherosclerotic Disease. Current Cardiology Reports. 12(6). 481–487. 7 indexed citations
19.
Tóth, Peter P., et al.. (2010). Abstract 12055: Prevalence of Lipid Abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006. Circulation. 122. 1 indexed citations
20.
Tóth, Peter P. & Michael H. Davidson. (2009). Leczenie dużymi dawkami statyn: korzyści i bezpieczeństwo intensywnej terapii hipolipemizującej. 3(3). 234–245. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Rosenson Breakdown of academic impact, for papers by Terry A. Jacobson Breakdown of academic impact, for papers by Harold Bays Breakdown of academic impact, for papers by Paul N. Durrington Breakdown of academic impact, for papers by Željko Reiner Breakdown of academic impact, for papers by Helen M. Colhoun Breakdown of academic impact, for papers by Raúl D. Santos Breakdown of academic impact, for papers by S. Matthijs Boekholdt Breakdown of academic impact, for papers by Michael H. Davidson Breakdown of academic impact, for papers by Chris J. Packard
Rankless by CCL
2026